- Pfizer says the company is in talks with the Indian government looking for a “fast-track approval path” for its COVID-19 vaccine.
- The company is also announcing a drug donation worth more than $ 70 million.
- India is reporting more than 300,000 new cases of the coronavirus, bringing its overall caseload to just under 20 million.
Pfizer CEO Albert Bourla said on Monday the company was in talks with the Indian government looking for a “fast-track approval path” for its COVID-19 vaccine.
He is also announcing a donation of medicines worth more than $ 70 million.
“Unfortunately, our vaccine is not registered in India although our application was submitted months ago,” he said.
“We are currently discussing with the Indian government a fast-track approval path to make our Pfizer-BioNTech vaccine available for use in the country. “
For the 12th consecutive day, India has reported more than 300,000 new cases of coronavirus, bringing its overall caseload to just under 20 million, while deaths from COVID-19 have increased by 3,417.
Read more: India reports first victim of foreign diplomat of COVID-19
With 368,147 new cases in the past 24 hours, the total number of infections in India stands at 19.93 million, while the total number of deaths is 218,959, according to data from the Ministry of Health.
Medical experts say real numbers across the country of 1.35 billion may be five to ten times higher than the official tally.
Hospitals have filled to capacity, medical oxygen supplies are depleted and morgues and crematoriums have been flooded as the country grapples with soaring cases.